Genomics and Biomarkers Unit, National Institute for Health and Welfare, Haartmaninkatu 8, Helsinki, Finland.
Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Eur J Hum Genet. 2018 Mar;26(3):324-329. doi: 10.1038/s41431-017-0049-3. Epub 2018 Jan 12.
Biobanks accumulate huge amounts of research findings, including participants' genomic data. Increasingly this leads to biobanks receiving research results that could be of clinical significance to biobank participants. The EU Horizon 2020 Project 'Genetics Clinic of the Future' surveyed European biobanks' perceptions of the legal and regulatory requirements for communicating individual research results to donors. The goal was to gain background knowledge for possible future guidelines, especially relating to the consent process. The Survey was implemented using a web-based Webropol tool. The questionnaire was sent at the end of 2015 to 351 European biobanks in 13 countries that are members of BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure-European Research Infrastructure Consortium). Seventy-two biobanks responded to the survey, representing each of the 13 BBMRI Member States. Respondents were mainly individuals responsible for the governance of biobanks. The replies indicate that the majority of the respondents thought that their national legislation allowed them to contact participants to communicate results, and that research participants had the right to request their results. However, respondents' understanding of their national legislation varied even within member states. Our results indicate that legislation applied to biobanks in many countries may be scattered and difficult to interpret. In BBMRI-ERIC, there is an ongoing discussion about the need for European recommendations on sharing genomic biobank results with donors, which may pave the way for more coherent global guidelines. Our results form a basis for this work.
生物库积累了大量的研究成果,包括参与者的基因组数据。越来越多的生物库收到了可能对生物库参与者具有临床意义的研究结果。欧盟 2020 年地平线项目“未来遗传学诊所”调查了欧洲生物库对向捐赠者传达个体研究结果的法律和监管要求的看法。目的是为可能的未来准则,特别是与同意过程相关的准则,提供背景知识。该调查使用基于网络的 Webropol 工具实施。调查问卷于 2015 年底发送给了 13 个欧盟成员国的 351 家欧洲生物库,这些国家是 BBMRI-ERIC(生物银行和生物分子资源研究基础设施-欧洲研究基础设施联盟)的成员。72 家生物库对调查做出了回应,代表了 BBMRI 的每个成员国。受访者主要是负责生物库管理的个人。答复表明,大多数受访者认为他们的国家立法允许他们联系参与者以传达结果,并且研究参与者有权要求其结果。然而,即使在成员国内部,受访者对其国家立法的理解也存在差异。我们的结果表明,许多国家的生物库适用的立法可能分散且难以解释。在 BBMRI-ERIC 中,正在讨论是否需要就与捐赠者分享基因组生物库结果提出欧洲建议,这可能为更一致的全球准则铺平道路。我们的结果为这项工作提供了基础。